Astera Labs (NASDAQ:ALAB) Raised to Strong-Buy at Zacks Research

Astera Labs (NASDAQ:ALAB) was upgraded by research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a report released on Tuesday,Zacks.com reports.

Other equities analysts have also recently issued research reports about the stock. Morgan Stanley boosted their price target on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Susquehanna lifted their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Rothschild & Co Redburn began coverage on shares of Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective for the company. Finally, UBS Group reiterated a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $325.25.

Astera Labs Stock Up 2.2%

NASDAQ:ALAB opened at $318.80 on Tuesday. The stock has a market cap of $55.31 billion, a P/E ratio of 157.82 and a beta of 3.84. The business’s 50-day moving average price is $358.62 and its two-hundred day moving average price is $238.55. Astera Labs has a twelve month low of $97.89 and a twelve month high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.Astera Labs’s revenue was up 104.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts expect that Astera Labs will post 2.7 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Bethany Mayer sold 686 shares of Astera Labs stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total transaction of $270,997.44. Following the transaction, the director directly owned 5,550 shares of the company’s stock, valued at approximately $2,192,472. This trade represents a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the sale, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,256,894 shares of company stock worth $362,763,135 in the last three months. Corporate insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Several institutional investors and hedge funds have recently made changes to their positions in ALAB. Reflection Asset Management bought a new stake in Astera Labs in the fourth quarter worth $25,000. Keating Financial Advisory Services Inc. bought a new position in shares of Astera Labs during the second quarter valued at about $25,000. Smartleaf Asset Management LLC increased its holdings in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in shares of Astera Labs in the fourth quarter worth about $33,000. Finally, Whipplewood Advisors LLC lifted its stake in shares of Astera Labs by 15,950.0% in the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after acquiring an additional 319 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Brokerages assign ALAB a consensus “Moderate Buy” rating, indicating generally favorable views among covering analysts. Astera Labs Given Consensus Recommendation of Moderate Buy
• Positive Sentiment: Northland Securities substantially raised its earnings forecasts, including FY2026 EPS to $2.75 from $1.82 and FY2027 EPS to $5.43 from $2.26. The revisions reflect expectations for strong growth in Astera’s AI connectivity business. Northland Securities Earnings Estimate Revisions
• Positive Sentiment: Analyst commentary highlights record growth, rising PCIe 6 demand and an expanding connectivity portfolio, potentially helping Astera compete with Marvell and Credo. ALAB Benefits From PCIe Demand
• Positive Sentiment: A bullish Seeking Alpha analysis sees Astera’s shift toward integrated, rack-level connectivity as an inflection point. Its Scorpio high-radix fabric switch could become the company’s largest revenue source, increase average selling prices and support cross-selling. The article assigns a Buy rating and a $370 price target. Astera Labs AI Fabric Inflection
• Positive Sentiment: AMD’s planned Helios rack-scale AI systems could benefit Astera as an ecosystem supplier, adding another potential demand driver beyond direct accelerator vendors. AMD’s Helios Launch Could Create Winners Beyond AMD Stock
• Neutral Sentiment: Despite raising its earnings estimates, Northland Securities maintained a “Market Perform” rating, signaling that strong growth expectations may already be reflected in ALAB’s valuation.
• Negative Sentiment: Astera Labs trades at a very high valuation, with a reported P/E ratio near 158 and a beta of 3.84. This leaves the stock particularly sensitive to profit-taking, changes in AI spending expectations and broader technology-sector weakness.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.